K Multicentre Study of Children with Opsoclonus Myoclonus Syndrome (UMSCOM) This is the UK arm of EU study Multinational Européan Trial for Children with the Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome. - UK Multicentre Study of Children with Opsoclonus Myoclonus Syndrome v1

Oxford University Hospitals NHS Trust0 个研究点目标入组 100 人开始时间: 2013年8月13日最近更新: 2013年9月23日

适应症

试验速览

暂无简介。

•For inclusion in the study all three numbered criteria below must be satisfied: 1) A diagnosis of OMS: Three out of the following four components must be evident: • Opsoclonus or ocular flutter (but not nystagmus) • Ataxia and/or myoclonus • Behavioural change and/or sleep disturbance • Neuroblastoma 2) Age at diagnosis between 6 months and 7 years (up to 8th birthday). 3) Signed informed consent has been given
•Are the trial subjects under 18? yes
•Number of subjects for this age range: 15
•F.1.2 Adults (18-64 years) no
•F.1.2.1 Number of subjects for this age range 0
•F.1.3 Elderly (>=65 years) no
•F.1.3.1 Number of subjects for this age range 0

•1. Opsoclonus, myoclonus or ataxia caused by another identified disease. 2. Prior or parallel use of chemotherapy (other than required for treatment of NB) 3. Steroid treatment lasting 14 days or more immediately before start of the study.

发起方